Shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) have received a consensus rating of “Moderate Buy” from the twenty-two brokerages that are covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $626.84.
A number of analysts have recently issued reports on the stock. UBS Group reduced their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Oppenheimer lifted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday. Cantor Fitzgerald increased their price objective on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, Morgan Stanley lowered their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th.
Institutional Investors Weigh In On UnitedHealth Group
UnitedHealth Group Stock Performance
UnitedHealth Group stock opened at $549.49 on Friday. The firm’s 50 day simple moving average is $587.48 and its 200-day simple moving average is $558.34. UnitedHealth Group has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The company has a market cap of $505.68 billion, a P/E ratio of 35.80, a price-to-earnings-growth ratio of 1.78 and a beta of 0.58.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.56 earnings per share. As a group, equities research analysts predict that UnitedHealth Group will post 27.6 EPS for the current year.
UnitedHealth Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.53%. UnitedHealth Group’s payout ratio is 54.72%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- Stock Average Calculator
- Trinity Capital CEO on Leading Private Credit’s High-Yield Growth
- What is MarketRank™? How to Use it
- Lululemon Surges On Q3 Report: Analysts Step in To Support Market
- Find and Profitably Trade Stocks at 52-Week Lows
- 10 Safe Investments with High Returns
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.